Company intelligence / Profile preview

JCB Laboratories

Wichita, Kansas, United States

Ownership: Private
Development stage: Other

Overview

JCB Laboratories (now Fagron Sterile Services US) is a leading 503B FDA-registered outsourcing facility specializing in the sterile compounding of pharmaceuticals for clinics, hospitals, ambulatory surgery centers, and physician offices, with a long-standing reputation for quality and compliance. The company is focused on critical need medications and resolves drug shortages in various therapeutic areas. No proprietary clinical trials or novel therapeutics are reported; products are compounded sterile preparations for immediate use by healthcare providers.[2][5][6]

Therapeutic areas: NephrologyOtherNeurologyMen's HealthOphthalmology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Angels for ChangePremier Inc.End Drug Shortages Alliance

Beyond the preview

Go deeper on JCB Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JCB Laboratories.

Explore the full profile